We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.
- Authors
Kurokawa, Kei; Iwashita, Toshihide; Murakami, Hideki; Hayashi, Hironori; Kawai, Kumi; Takahashi, Masahide
- Abstract
SNT/FRS2 is a lipid anchored docking protein that contains an amino-terminal myristylation signal, followed by a phosphotyrosine-binding (PTB) domain and a carboxy-terminal region with multiple tyrosine residues. Here we show that the SNT/FRS2 PTB domain binds to RET receptor tyrosine kinase activated by glial cell line-derived neurotrophic factor (GDNF) or multiple endocrine neoplasia (MEN) 2 mutations. Analyses by site directed-mutagenesis revealed that it binds to tyrosine 1062 in RET that is also known to be a binding site for the SHC adaptor protein. Whereas SHC bound to RET was associated with GRB2 and GAB1 proteins, SNT/FRS2 was associated with GRB2 only, suggesting that SNT/FRS2 is involved mainly in the activation of the RAS/mitogen activated protein kinase (MAPK) pathway but not the phosphatidylinositol 3-kinase (PI3-K)/AKT pathway. In addition, phosphorylated SNT/FRS2 appeared to directly complex with SHP-2 tyrosine phosphatase. These results suggest that tyrosine 1062 in RET provides a site for the interaction of multiple signaling molecules and that the balance of SHC and SNT/FRS2 binding may affect the nature of the intracellular signaling for cell proliferation, differentiation and survival induced by activated RET. Oncogene (2001) 20, 1929–1938.
- Subjects
PROTEINS; LIPIDS; TYROSINE
- Publication
Oncogene, 2001, Vol 20, Issue 16, p1929
- ISSN
0950-9232
- Publication type
Article
- DOI
10.1038/sj.onc.1204290